Extended spectrum β-lactamase-and AmpC β-lactamase-producing Enterobacterales associated with urinary tract infections in the New Zealand community: A case-control study.

(c) The Author/sOBJECTIVES: To assess whether having a pet in the home is a risk factor for community-acquired urinary tract infections associated with extended spectrum β-lactamase (ESBL)- or AmpC β-lactamase (ACBL)- producing Enterobacterales. METHODS: An unmatched case-control study was conducted between August 2015 and September 2017. Cases (n=141) were people with community-acquired urinary tract infection (UTI) caused by ESBL- or ACBL- producing Enterobacterales. Controls (n=525) were recruited from the community. A telephone questionnaire on pet ownership, and other factors was administered, and associations were assessed using logistic regression. RESULTS: Pet ownership was not associated with ESBL- or ACBL-producing Enterobacterales related human UTIs. A positive association was observed for recent antimicrobial treatment, travel to Asia in the previous year, and a doctor's visit in the previous six months. Among isolates with an ESBL-/ACBL-producing phenotype 126/134 (94%) were Escherichia coli, with sequence type (ST) 131 being the most common (47/126). CONCLUSIONS: Companion animals in the home were not found to be associated with ESBL- or ACBL-producing Enterobacterales related community-acquired UTI in New Zealand. Risk factors included overseas travel, recent antibiotic use, and doctor visits.Published onlin

Perforin expression in cytotoxic Tcells of infants with respiratory syncytial virus bronchiolitis

Perforin je protein smješten u sekretornim granulama citotoksičkih T-limfocita. Zajedno s ostalim komponentama granula nužan je za lizu stanica organizma inficiranih unutarstaničnim patogenima. Ispitali smo izražaj perforina u citotoksičkim T-limfocitima dojenčadi s bronhiolitisom uzrokovanim respiracijskim sincicijskim virusom (RSV). Uzorci periferne krvi prikupljeni su za vrijeme primarne infekcije i rekonvalescencije u inficirane dojenčadi (n=12) i od kontrolne skupine zdrave djece koja su odgovarala po dobi i spolu. Analiza prikupljenih podataka pokazala je približno jednak postotak citotoksičkih T-limfocita koji izražavaju perforin u sve tri skupine ispitanika. Međutim, pronađene su razlike u razini izražaja perforina po pojedinom limfocitu između rekonvalescentne djece i zdravih kontrola, što upućuje na trajniji poremećaj stanične imunosti nakon prestanka infekcije RSV-om.Perforin is a protein located in secretory granules of cytotoxic T cells. Together with other granules\u27 proteins perforin is necessary for lysis of host\u27s cells infected with intracellular pathogens. We investigated peforin expression in cytotoxic T cells of infants with bronchiolitis caused by respiratory syncytial virus (RSV). The peripheral blood samples were obtained from hospitalized infants during primary infection and after the resolution of the disease (n=12), and from the control group of age- and gender-matched healthy children. Analysis of the data revealed that the percentage of perforin-expressing cytotoxic T cells was similar in all three groups of tested subjects. However, there were differences in perforin expression levels in cytotoxic T cells between once-infected infants and their healthy controls. This indicates an ongoing disturbed cellular immune response even after the resolution of RSV infection

Persistent organochlorine compounds in human milk collected in Croatia over two decades

The distribution and time trend of organochlorine pesticide (OCP), polychlorinated biphenyl (PCB), and polychlorinated dibenzo-p-dioxin/polychlorinated dibenzofuran (PCDD/PCDF) concentrations in human milk samples from Croatia collected in 1981-2003 are presented. Between 1981/1982 and 1987/1989, the concentrations of HCB, beta-HCH, DDE, and total PCBs decreased about 50%, while for the last decade, the concentrations have been decreasing very slowly. In 2002/2003 the range of PCB congeners and OCPs was from below the limit of determination to 332 ng g(-1) milk fat. PCDD/PCDF concentrations in human milk samples collected in 1981-2000 ranged between 5.2 and 26.7 pg I-TEQ g(-1) milk fat and showed a decreasing trend

The burden of Legionnaires' disease in New Zealand (LegiNZ): A national surveillance study

Background: Legionnaires' disease is under-diagnosed because of inconsistent use of diagnostic tests and uncertainty about whom to test. We assessed the increase in case detection following large-scale introduction of routine PCR testing of respiratory specimens in New Zealand. Methods: LegiNZ was a national surveillance study done over 1-year in which active case-finding was used to maximise the identification of cases of Legionnaires' disease in hospitals. Respiratory specimens from patients of any age with pneumonia, who could provide an eligible lower respiratory specimen, admitted to one of 20 participating hospitals, covering a catchment area of 96% of New Zealand's population, were routinely tested for legionella by PCR. Additional cases of Legionnaires' disease in hospital were identified through mandatory notification. Findings: Between May 21, 2015, and May 20, 2016, 5622 eligible specimens from 4862 patients were tested by PCR. From these, 197 cases of Legionnaires' disease were detected. An additional 41 cases were identified from notification data, giving 238 cases requiring hospitalisation. The overall incidence of Legionnaires' disease cases in hospital in the study area was 5·4 per 100 000 people per year, and Legionella longbeachae was the predominant cause, found in 150 (63%) of 238 cases. Interpretation: The rate of notified disease during the study period was three-times the average over the preceding 3 years. Active case-finding through systematic PCR testing better clarified the regional epidemiology of Legionnaires' disease and uncovered an otherwise hidden burden of disease. These data inform local Legionnaires' disease testing strategies, allow targeted antibiotic therapy, and help identify outbreaks and effective prevention strategies. The same approach might have similar benefits if applied elsewhere in the world. Funding: Health Research Council of New Zealand